Objectives: To explore assessment of supra-annular structure for self-expanding transcatheter heart valve (THV) size selection in patients with bicuspid aortic stenosis (AS).
Multidetector computed tomography is now a standard imaging modality for device sizing in TAVR [7] . Since the aortic valve annulus typically represents the tightest part of the aortic root, sizing of aortic valve annulus has been regarded as the "gold standard" in transcatheter heart valve (THV) size selection [8, 9] . In the TAVR era, balloon aortic valvuloplasty is applied to provide additional information for THV size selection when encountering a borderline annulus [10] , or as a bridge to TAVR procedure [11] .
Clinical experience in China suggests bicuspid aortic valves and heavy calcium burden are more common among TAVR candidates [12] . Morphological characteristics at supra-annular structure (from annulus to the level of sinotubular junction) are quite complex in bicuspid AS, especially concomitant with heavily calcified leaflets. Because only two leaflet hinge points provide the definition of the annulus plane, current CT-based annulus measurements might not be accurate under these circumstances. From our clinical practice, "waist sign" above the annulus during balloon aortic valvuloplasty in TAVR was often observed in patients with bicuspid AS, indicating that the supra-annular structure may serve a key role in anchoring the THV. Therefore, we sought to investigate sizing strategies for self-expanding device size selection in TAVR based on supra-annular structure assessment for patients with bicuspid AS.
| M A TER I A LS A N D M ETH OD S

| Patients
From April 2016 to April 2017, 70 consecutive patients with severe AS underwent TAVR at Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Twelve patients with bicuspid AS implanted with self-expanding THVs using supra-annular assessment for device size selection were included in this retrospective study.
TAVR appropriateness for each AS patient was determined by the dedicated heart team of our hospital. Clinical, procedural, and imaging data were prospectively included in our TAVR database. 
| Echocardiography
The diagnosis of severe aortic stenosis was confirmed with transthoracic echocardiography (TTE) according to established guidelines [13, 14] . Function of the THVs was evaluated by TTE at 30-day followup. TTE measurements, including aortic valve area, mean gradient, maximal velocity, and left ventricular ejection fraction (LVEF) were documented. Baseline aortic regurgitation and post-TAVR paravalvular leakage grade were classified as none/trace (0), mild (1), moderate (2), or severe (3) [14] .
| Dual source computed tomography data acquisition and analysis
Dual source computed tomography (DSCT) was performed in all patients pre-procedurally for aortic root measurement and access route selection. All DSCT examinations were performed with the second generation dual-source CT (SOMATOM Definition Flash, Siemens Medical Solutions, Germany). The scan area was craniocaudal from the subclavian artery to the iliofemoral branches. Prospective ECG gating with a pitch of 2.4 was performed. Around 60-80 ml of iodine-containing contrast agent (Omnipaque 370 mg I/ml, GE Healthcare, Shanghai, China) was injected with a dual head power injector (Mallinckrodt, American) at a flow rate of 4 ml/s followed by 60 ml 0.9% saline solution at the same flow rate. A bolus tracking method was used in the descending aorta with a pre-set threshold of 180 Hounsfield Units (HU) to achieve optimal synchronization. The tube voltage was 100 kV, DSCT datasets were analyzed using 3mensio 8.0 (3mensio Medical Imaging BV, the Netherlands) [15] . Bicuspid aortic valve was diagnosed based on short-axis images of the aortic valve on DSCT.
Bicuspid aortic valve was classified by the number of raphes (type0, type1 and type2) [16] . The orientation of raphe is defined in relation to the sinuses as left-right (LR), right-non (RN), and left-non (LN).
Maximal, minimal, mean, and perimeter-derived diameter of annulus, mean diameter of sinotubular junction (STJ), and coronary ostium height were measured as previous described [8] . Due to the deformity of bicuspid aortic valve, only the maximum and minimum diameter of the sinus of Valsalva were measured. The threshold for detecting aortic root calcification was set at 650 HU; then, calcium volume was measured within the region from left ventricular outflow tract (LVOT) to the leaflet tips. Distribution of calcification was classified as symmetrical or asymmetrical, and the specific distribution was described.
| TAVR procedure
All TAVR procedures were performed by trans-femoral access under general anesthesia or local anesthesia with sedation. Two domestic self-expanding THVs, Venus A (Venus Medtech Inc., Hangzhou, China) and VitaFlow valve (Shanghai MicroPort CardioFlow Medtech Co., Ltd., Shanghai, China) were selected to this patient population.
The design of both devices is similar to that of the CoreValve. Clinical outcomes were evaluated by VARC-2 criteria [14] . Angiographic aortic regurgitation and gradients reduction immediately after TAVR were measured as previously described [17, 18] . Implantation depth was defined as the distance from the native aortic annulus plane to the left ventricular edge of THV by fluoroscopy [19, 20] . Mean implantation depth was defined as the average of the left and right side implantation depths. Procedural information and outcomes 
| Follow-up
Clinical and TTE follow up were performed at 30d at our center.
Indexed effective orifice area was calculated to quantify prosthesispatient mismatch (PPM). Clinical improvement was evaluated by New
York Heart Association (NYHA) class. All outcomes were defined according to VARC-2 criteria [14] .
| Statistical analysis
Data are expressed as mean 6 SD or as median (interquartile range).
The data were analyzed using SPSS statistics 21.0 (SPSS Inc., Chicago, Illinois, USA). Table 2 .
| RE S U L TS
| Baseline characteristics
The calcium volume measured at the threshold of 650U was 1052.0 6 726.2 mm 3 and distribution of calcification in 7 patients was asymmetric.
3.2 | Supra-annular structure assessment by sequential balloon sizing, device size selection, and procedural outcomes 
| 991
Compared with an annulus-based sizing strategy, the final selected device was one size smaller in nine patients, two sizes smaller in two patients, and the same in one patient Devices were successfully deployed in all 12 patients, and post-dilation was performed in eight patients. No severe complications, including mortality, moderate to severe PVL, TAV-in-TAV and coronary obstruction were found. Mean implantation depth was 4.6 6 3.1mm (Table 3) .
Patient 2 was a typical aortic stenosis patient with type 0 bicuspid AS ( Figure 3A ) and 32 mm VENUS A would be recommended according to annulus based sizing strategy ( Figure 3B ). However, waist sign was obvious during balloon sizing with 18 mm Z-Med balloon ( Figure   3C ), and calculated average diameter was 22.9 mm, so a 26 mm VENUS A was selected. A prosthesis was successfully deployed above the annulus and the implantation depth was 0 and 22 mm in the left and right side ( Figure 3D ). DSCT follow up showed the VENUS A was anchored by the supra-annular structure while not even attached to the annulus ( Figure 3E,F) , indicating the important role of supra-annular structure for the device anchoring and sizing. 
| D ISC USSION
We report Hangzhou's experience, with supra-annular structure assessments by sequential balloon sizing for device size selection, in TAVR patients with bicuspid AS for the first time. Sequential balloon sizing was successfully performed to assess the supra-annular structure in all 12 patients. A smaller device size was selected in all but one patient, and the outcomes were satisfactory with 100% procedural success, no 30d mortality, good hemodynamic results, and heart function recovery.
Bicuspid aortic valve deformity is a heritable disease with an estimated prevalence of 0.5%-2% [22] . Unfavorable morphological characteristics of bicuspid aortic valve patients, such as annular eccentricity, asymmetrical leaflet calcification, unequally-sized leaflets, and concomitant aortopathy [23] increase possibility of deeper implantation, PVL, TAV-in-TAV, annulus rupture, aortic dissection, etc. during TAVR procedures. Thus, early TAVR clinical trials and guidelines regarded bicuspid AS as a relative contraindication [24, 25] , which resulted in a lack of data on TAVR for patients with bicuspid AS. Recently, a few studies showed encouraging short-and mid-term clinical outcomes in bicuspid AS patients undergoing TAVR [6, 26] . It is reported that the proportion of bicuspid AS is from 37.5% to 47.5% in Chinese TAVR patients [12, 27] . Therefore, it is especially important for Chinese interventionalists to improve the outcomes with the only available first-generation domestic self-expanding THVs, VENUS A and VitaFlow Valve at the present time.
Annulus-based device selection from CT measurement is the standard sizing strategy for tricuspid AS; however, no standard sizing for bicuspid AS has been developed so far. Even though CT provides precise anatomic aortic root information, it is insufficient in revealing the mechanical characteristics of the annulus or supra-annular structure for THV anchoring. Previously, balloon sizing was performed in patients with borderline annulus or bicuspid AS [28] . However, the purpose of previous balloon sizing was focused on annulus instead of supraannular structure [28, 29] . Balloon sizing provides information of supraannular mechanical characteristics by observation of the balloon waist sign in conjunction with contrast aortogram and AR evaluation, which has not been descripted before. Interestingly, THVs were deployed above the annulus in some patients at our center, indicating that the supra-annular structure provides enough anchoring force. Our data demonstrated an advantage strategy for selection of a THV in bicuspid AS patient population.
Base on the principle of supra-annular structure assessment, downsizing of the self-expanding prosthesis was used in 91.7% of our bicuspid AS patient population. Good procedural outcomes demonstrated that our strategy avoided inadequate oversizing which may lead to deep implantation, paravalvular leak, conduction abnormality, and prosthesis under-expansion. Compared with the CoreValve US High Risk Pivotal Trial, our strategy did not increase the rate or severity of PPM [21] . Therefore, our strategy is both feasible and safe based on the experience of initial 12 cases.
| S T U DY LI M I TA TI ON S
Admittedly, there are some limitations in our study. Firstly, repeated rapid ventricular pacing during sequential balloon sizing may have unfavorable impact on hemodynamic stability, although only one balloon was used in majority of the cases, and heart function deterioration was not observed in our entire study cohort. Secondly, balloon valvuloplasty may induce more native valve debris, which is a probable cause of ischemic stroke. One patient suffered from a non-disabling stroke in our study; however previous published data suggests that pre-dilation is not associated with stroke [30] . The impact of sequential balloon sizing on stroke may need further research. Thirdly, the sample size and following up of the current study is small and short. A prospective randomized controlled trial to test the efficacy of supra-annular structure based sizing strategy by sequential balloon sizing, as well as longterm follow-up study is currently ongoing in our center.
| C ONC LUSI ON S
A supra-annular assessment based sizing strategy by sequential balloon sizing is feasible for patients with bicuspid AS during TAVR procedure.
